These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28949293)

  • 1. Identification of highly-protective combinations of
    França CT; White MT; He WQ; Hostetler JB; Brewster J; Frato G; Malhotra I; Gruszczyk J; Huon C; Lin E; Kiniboro B; Yadava A; Siba P; Galinski MR; Healer J; Chitnis C; Cowman AF; Takashima E; Tsuboi T; Tham WH; Fairhurst RM; Rayner JC; King CL; Mueller I
    Elife; 2017 Sep; 6():. PubMed ID: 28949293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection.
    França CT; Hostetler JB; Sharma S; White MT; Lin E; Kiniboro B; Waltmann A; Darcy AW; Li Wai Suen CS; Siba P; King CL; Rayner JC; Fairhurst RM; Mueller I
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004639. PubMed ID: 27182597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria.
    Céspedes N; Li Wai Suen CSN; Koepfli C; França CT; Felger I; Nebie I; Arévalo-Herrera M; Mueller I; Corradin G; Herrera S
    PLoS One; 2017; 12(6):e0179863. PubMed ID: 28651021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.
    Cole-Tobian JL; Michon P; Biasor M; Richards JS; Beeson JG; Mueller I; King CL
    Infect Immun; 2009 Sep; 77(9):4009-17. PubMed ID: 19564376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.
    King CL; Michon P; Shakri AR; Marcotty A; Stanisic D; Zimmerman PA; Cole-Tobian JL; Mueller I; Chitnis CE
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8363-8. PubMed ID: 18523022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
    Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
    Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.
    Hostetler JB; Sharma S; Bartholdson SJ; Wright GJ; Fairhurst RM; Rayner JC
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004264. PubMed ID: 26701602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
    Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
    Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women.
    Requena P; Rui E; Padilla N; Martínez-Espinosa FE; Castellanos ME; Bôtto-Menezes C; Malheiro A; Arévalo-Herrera M; Kochar S; Kochar SK; Kochar DK; Umbers AJ; Ome-Kaius M; Wangnapi R; Hans D; Menegon M; Mateo F; Sanz S; Desai M; Mayor A; Chitnis CC; Bardají A; Mueller I; Rogerson S; Severini C; Fernández-Becerra C; Menéndez C; Del Portillo H; Dobaño C
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005009. PubMed ID: 27711158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain.
    George MT; Schloegel JL; Ntumngia FB; Barnes SJ; King CL; Casey JL; Foley M; Adams JH
    mSphere; 2019 May; 4(3):. PubMed ID: 31092602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain-Transcending Inhibitory Antibodies against Homologous and Heterologous Strains of Duffy Binding Protein region II.
    Wongkidakarn S; McHenry AM; Sattabongkot J; Adams JH; Chootong P
    PLoS One; 2016; 11(5):e0154577. PubMed ID: 27145131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.
    Nicolete VC; Frischmann S; Barbosa S; King CL; Ferreira MU
    J Infect Dis; 2016 Nov; 214(10):1539-1546. PubMed ID: 27578850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.
    França CT; Li Wai Suen CSN; Carmagnac A; Lin E; Kiniboro B; Siba P; Schofield L; Mueller I
    Malar J; 2017 Sep; 16(1):386. PubMed ID: 28946883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.
    Tran TM; Oliveira-Ferreira J; Moreno A; Santos F; Yazdani SS; Chitnis CE; Altman JD; Meyer EV; Barnwell JW; Galinski MR
    Am J Trop Med Hyg; 2005 Aug; 73(2):244-55. PubMed ID: 16103583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.
    He WQ; Shakri AR; Bhardwaj R; França CT; Stanisic DI; Healer J; Kiniboro B; Robinson LJ; Guillotte-Blisnick M; Huon C; Siba P; Cowman A; King CL; Tham WH; Chitnis CE; Mueller I
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0006987. PubMed ID: 30768655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.
    Salavatifar M; Zakeri S; Abouie Mehrizi A; Mirkhazemi S; Dinparast Djadid N
    Arch Iran Med; 2015 Dec; 18(12):834-43. PubMed ID: 26621016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1.
    Pandey JP; Morais CG; Fontes CJ; Braga EM
    Malar J; 2010 Aug; 9():229. PubMed ID: 20696056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.
    Zakeri S; Babaeekhou L; Mehrizi AA; Abbasi M; Djadid ND
    Am J Trop Med Hyg; 2011 Jun; 84(6):944-50. PubMed ID: 21633032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period.
    Medeiros CMP; Moreira EUM; Pires CV; Torres LM; Guimarães LFF; Alves JRS; Lima BAS; Fontes CJF; Costa HL; Brito CFA; Sousa TN; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
    PLoS One; 2020; 15(5):e0232786. PubMed ID: 32379804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.